Summary

How STAA maps according to Revere

Sector Level Count
Industries 1
Sectors 1
Subsectors 1
Product/Service Groups 6

Specific product example for STAA

Product Hierarchy
Healthcare
Medical Devices
Ophthalmology
Surgical
Procedure/Region Specific
Cataract
Instruments
Electrical
Phacoemulsification

Company Highlights:

Market Cap. 373.110
Current Shares Outstnd. 35.7
Contact Name Deborah Andrews
Contact Phone (626)3037902
City, State Monrovia, CA
Dividends Per Common Share n/a
Dividend Yield n/a
IH % Shares Outst. 80.33%
Number of Employees 279
Revenue Per Employee 233,888.1
Book Value Per Share 0.80
5 Year CAGR in Revenues % 1.39
5 Year CAGR in Earnings % n/a
Asset Turnover 0.33
Fiscal Year End 12/31/2011
Next Reporting Period Dec, 2011

Business Description:

STAAR Surgical Company (STAAR) is engaged in developing, producing, and marketing intraocular lenses (IOLs) and other products for minimally invasive ophthalmic surgery. Principal products are IOLs and implantable Collamer lenses (ICLs). IOLs are prosthetic intraocular lenses used to restore vision that has been adversely affected by cataracts, and include the Company?s lines of silicone and Collamer IOLs and the Preloaded Injector (a silicone or acrylic IOL preloaded into a single-use disposable injector). ICLs, consisting of the Company?s Visian ICL and TICL, are intraocular lenses used to correct refractive conditions, such as myopia (near-sightedness), hyperopia (far-sightedness) and astigmatism. The Company also sells other instruments, devices and equipment that are manufactured either by the Company or by others in the ophthalmic products industry. Inc. On March 2, 2010, the Company announced the divestiture of its German distribution subsidiary, Domilens GmbH.

Chart:

Last Price 10.46
Price Chg. 0.00
Price Chg. % 0.00%
Open Price 10.80
High Price 10.88
Low Price 10.40
52w High Price 11.79
52w Low Price 4.41
Volume 277,018
30d Avg. Volume 161,816
STAA - Chart
* Quotes delayed 20 minutes.

Competitors by Products

Products Manufactured/Services Performed/Product Name(s) - Competitors (Tickers)/Product Name(s):
Healthcare
Medical Devices
Ophthalmology
Surgical
Procedure/Region Specific
Cataract
Instruments
Electrical
Phacoemulsification

Products:

  • Cruise Control
  • Sonic WAVE Phacoemulsification System

Abbott Laboratories (ABT) Products:

  • Abbott Medical Optics - Diplomax II Phacoemulsification System
  • Abbott Medical Optics - Sovereign Compact Phacoemulsification System
  • Abbott Medical Optics - WhiteStar Signature Phacoemulsification System

Novartis AG (ADR) (NVS) Products:

  • Alcon Constellation Vision System
  • Alcon Infiniti Cataract Extraction System
  • Alcon Laureate Compact Phacoemulsification System
  • Alcon OZil Torsional Handpiece
Manual Instruments

Products:

  • Epiphany Injector System
  • KS-X Preloaded Hydrophobic Acrylic Injector
  • Microstaar Injecting System
  • STAAR Japan, Inc. Preloaded Injectors

Abbott Laboratories (ABT) Products:

  • Abbott Medical Optics - Emerald IOL Delivery System
  • Abbott Medical Optics - SilverT IOL Delivery System

Becton, Dickinson and Co. (BDX) Products:

  • BD Ophthalmic Cataract Products
  • BD Ophthalmic Surgery Kits

Novartis AG (ADR) (NVS) Products:

  • Alcon A-OK Surgical Knives
  • Alcon ClearCut Dual-Bevel Knives
Intraocular Lenses
Foldable

Products:

  • nanoFLEX Toric Collamer Single Piece IOL
  • Afinity Collamer Aspheric IOL
  • Toric IOL Series
  • nanoFLEX Collamer Aspheric IOL + nanoPOINT Injector System

Abbott Laboratories (ABT) Products:

  • Abbott Medical Optics - ClariFlex
  • Abbott Medical Optics - ReZoom Multifocal IOL
  • Abbott Medical Optics - Sensar Acrylic IOL Series
  • Abbott Medical Optics - Synchrony Dual Optic Accommodating IOL And Pre-Loaded Injector
  • Abbott Medical Optics - Tecnis Aspheric Acrylic/Silicone IOL Series
  • Abbott Medical Optics - Tecnis Multifocal IOL

Novartis AG (ADR) (NVS) Products:

  • Alcon AcrySof CACHET Phakic Intraocular Lens
  • Alcon AcrySof Intraocular Lens Series
  • Alcon AcrySof IQ Intraocular Lens
  • Alcon AcrySof IQ ReSTOR
  • Alcon AcrySof IQ Toric IOL
  • Alcon CIBA Vision MemoryLens Series
  • Alcon CIBA Vision PMMA Lenses
Viscoelastics

Products:

  • STAARVISC II

Abbott Laboratories (ABT) Products:

  • Abbott Medical Optics - Healon Series

Anika Therapeutics, Inc. (ANIK) Products:

  • AMVISC
  • AMVISC Plus
  • ShellGel
  • STAARVISC II

Baxter International Inc. (BAX) Products:

  • Hylenex (Recombinant Human Hyaluronidase)

Novartis AG (ADR) (NVS) Products:

  • Alcon Cellugel Viscoelastic
  • Alcon DisCoVisc Viscoelastic
  • Alcon DuoVisc Viscoelastic System
  • Alcon ProVisc Viscoelastic
  • Alcon VISCOAT Viscoelastic
Glaucoma
Implants

Products:

  • AquaFlow

Abbott Laboratories (ABT) Products:

  • Abbott Medical Optics - Baerveldt Glaucoma Implant

Novartis AG (ADR) (NVS) Products:

  • Alcon Ex-PRESS Glaucoma Filtration Device

Opko Health Inc (OPK) Products:

  • Aquashunt

RTI Biologics Inc. (RTIX) Products:

  • Tutogen Medical Tutoplast Processed Allografts
Refractive (Vision Correction)
Intraocular Lenses

Products:

  • Visian TICL (Toric Implantable Collamer Lens)
  • Visian ICL (Implantable Collamer Lens)

Abbott Laboratories (ABT) Products:

  • Abbott Medical Optics - Verisyse Phakic Intraocular Lens

Novartis AG (ADR) (NVS) Products:

  • Alcon CIBA Vision PRL (Phakic Refractive Lens)

Key Financials

FY Ends October
Period Length/End 3 months
ending
09/30/2011 		3 months
ending
07/01/2011 		3 months
ending
10/01/2010 		12 months
ending
12/31/2010 		12 months
ending
01/01/2010 		12 months
ending
01/02/2009
Total Revenue 15.3 16.3 13.2 55.0 51.1 49.8
Gross Margin % 68.45 66.76 62.8 63.82 61.35 58.43
Operating Income 0.7 1.2 -1.2 -2.9 -4.9 -22.8
Operating Margin % 4.83 7.19 -9.06 -5.22 -9.56 -45.87
Tax Rate % 73.54 35.26 -44.39 -11.74 -20.08 -4.08
Income After Taxes 0.1 0.9 -1.2 -4.1 -6.9 -24.8
Net Income Margin % 0.5 5.29 -8.8 -7.48 -13.52 -49.93
F.D. EPS - Incl. Xord. Items 0.00 0.02 -0.03 0.00 -0.19 -0.79
Book Value Per Share 0.80 0.72 0.62 0.64 0.61 0.54

Ratios

P/R Ratio (TTM) 6.14
P/E Ratio (TTM) 712.55
Price To Free Cash Flow (TTM) n/a
Price To Book Value 12.69
Net Assets to Market Cap. % 10.96%
Beta 0.96
Days to Sell Inventory 200.52
Current Ratio 2.79
Quick Ratio 1.84
Interest Coverage n/a
Debt to Market Cap. % 0.26%
Return on Equity % 7.71
Return on Assets % 4.77
Return on Invested Capital % 6.85

Business/Geographical Segments

Geographic Segments

Source:  10-Q Nov 02, 2011
  External Revenue Total Revenue
U. S. 3.2 21.0% 3.2 21.0%
Japan 4.0 26.4% 4.0 26.4%
South Korea 2.1 13.6% 2.1 13.6%
China 1.8 12.0% 1.8 12.0%
Other 4.1 27.0% 4.1 27.0%
Segment Total 15.3 100.0% 15.3 100.0%
Consolidated Total 15.3   15.3